Sign up
Quantellect · Congress · Trade Detail
NASDAQ: CRSPCrispr Therapeutics AG
RepublicanHouse

Marjorie Taylor Greene bought Crispr Therapeutics AG (NASDAQ: CRSP)

Marjorie Taylor Greene (R-GA), a U.S. Representative, has disclosed 1 trade in Crispr Therapeutics AG (CRSP) since 2021, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Marjorie Taylor Greene bought $1,001 - $15,000 of Crispr Therapeutics AG (NASDAQ: CRSP) on January 21, 2021. Since that trade, CRSP is down -73.83% against the S&P 500 up +107.35%, an outperformance of -181.18%.

Data updated

CRSP trades
1
Disclosed Vol
$8K
Buys
1
100%
Sells
0
0%
Buy / Sell
All buys
ratio
First → Last
2021

Marjorie Taylor Greene's CRSP trades vs the price

CRSP is down -73.83% since Marjorie Taylor Greene bought on January 21, 2021, versus +107.35% for the S&P 500.

Performance since this trade

Price change since trade
-73.83%
S&P 500 change since trade
+107.35%
Outperformance vs S&P 500
-181.18%

All Marjorie Taylor Greene CRSP trades

TradedTypeSizeReturnEst. profit
January 21, 2021BUY$185.10-73.83%-$6K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Marjorie Taylor Greene & CRSP trading FAQ

Is it legal for Marjorie Taylor Greene to trade Crispr Therapeutics AG (CRSP) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Crispr Therapeutics AG (CRSP), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Marjorie Taylor Greene buy CRSP?

Marjorie Taylor Greene disclosed a purchase of $1,001 - $15,000 of Crispr Therapeutics AG (CRSP) on January 21, 2021, according to public STOCK Act filings.

How has CRSP performed since Marjorie Taylor Greene's trade?

Since Marjorie Taylor Greene bought CRSP on January 21, 2021, the stock is down -73.83%, versus +107.35% for the S&P 500 over the same period, an outperformance of -181.18%.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional CRSP trades?

Quantellect tracks every disclosed congressional trade in Crispr Therapeutics AG (CRSP) on the Crispr Therapeutics AG congressional trading page, which aggregates filings across all members of Congress.

Marjorie Taylor Greene's CRSP tradesAll congressional filings for Crispr Therapeutics AGMarjorie Taylor Greene's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.